undamentalytics Newsletter
Sign in

Core Scientific, Inc. (CORZ) stock

Add to watchlist

Add holding +

NASDAQ: CORZ Nasdaq Internet Services & Infrastructure Next results ~November 5, 2026

C Fundamentals grade

Core Scientific, Inc. is a US-listed company in the internet services & infrastructure industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$2.5

Forward price-to-earnings vs peers

Base case. Range ~$2.1–$4.7. Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Core Scientific, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders2 buying, 1 selling5 purchases and 49 sales by directors and officers, last 12 monthsInsider trades
  • Funds223 adding, 190 cuttingOf 70 active managers that changed their stake, 37 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Core Scientific files

Where Core Scientific stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $440m, up 26.4% on a year earlier, against a decline of 13.7% a quarter earlier. That growth ranks 3 of 16 among the internet services & infrastructure companies we cover. Our price-to-sales vs peers value is $2.97 a share, against a share price of $14.69.

Source: 10-Q filed July 28, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Core Scientific, Inc.'s trailing-twelve-month revenue grew 26.4% year on year, with a free-cash-flow margin of -217.5%. Where it stands out: change in growth rate of +40.0pp ranks 2 of 34 internet services & infrastructure companies we cover. Where it lags: long-term debt as % of assets of 81.7% ranks 23 of 25 internet services & infrastructure companies we cover.

Current signal Revenue growth accelerating: TTM revenue growth rose to 26.4% (+40.0pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 26.4% over the last 12 months, against a median of 10.1% for internet services & infrastructure companies we cover.
  • Growth speeding up. The growth rate is 40.0 points higher than a quarter earlier.

Things to watch

  • Loss-making. Operating margin is -127.4%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 75.8 points on a year ago.
  • Burning cash. Free cash flow was -217.5% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 21.3% of revenue, against a median of 12.4% for internet services & infrastructure companies we cover: a real cost that cash-flow figures leave out.
  • High debt. Long-term debt exceeds cash by $2.5bn, more than 1.5 times annual revenue.
  • Volatile shares. Over the past year the shares showed annualised volatility of 73% and a beta of 3.1 against the S&P 500.

Latest results: FY2026 Q2

Filed July 28, 2026
Earnings per share
-$0.04 against an average estimate of -$0.06: beat by 27.2%
Revenue
$164m, up 108.8% on a year earlier
Share reaction
-12.6% in the first session after the results on July 28, 2026, against -1.3% for the S&P 500
Next report
November 5, 2026; average EPS estimate -$0.00

Core Scientific's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-5.6%
  • 1 week-7.4%
  • 1 month-24.0%
  • This year-14.1%
  • 1 year-41.9%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$440M
Operating margin
-127.4%
Net margin
-324.9%
EPS (TTM, diluted)
$-4.62

Growth

Revenue growth
+26.4%
Change in growth rate
+40.0 pts
Share count change
−0.4%

Earnings

Last results
July 28, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Agreement
  3. Announcement
  4. Leadership
  5. Results
  6. Share issue

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Core Scientific, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Core Scientific, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 12.4%: the 10-year Treasury yield (4.9%) plus a beta of 1.67 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: the projected cash flows don't support a positive value
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$2.5 ~$2.1–$4.7 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: book value or earnings not available
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. — 0 Does not apply: no positive value
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$2.5 ~$2.1–$4.7 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Core Scientific, Inc. with Internet Services & Infrastructure in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

16 /100

Weak moat

How hard Core Scientific's competitive advantage looks for rivals to wear away, judged from 5 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -66.8% of total assets over 5 years.

  • Pricing power 3 / 20

    Gross margin has been a median 28.3%, moving by 14.9 percentage points (standard deviation) across 5 years.

  • Durability 10 / 20

    Operating margin has been a median -125.1%; its worst year was -192.0%.

  • Cash conversion 4 / 20

    Free cash flow was positive in 2 of 5 years, at a median -8.5% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (21 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, before the open. Analysts expect revenue of $194m and EPS of −$0.00 (range −$0.05 to $0.06) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$3.79 −522% $676m +112%
Next $0.16 +104% $1.1bn +70%

Next year's EPS estimate has moved −37.4% in 90 days, across 4 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +312.2% on 90 days ago. In the last 30 days, 0 analysts raised Core Scientific, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Core Scientific, Inc., last 90 days
−$4.00 −$2.00 $0.00 $2.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.92 Current fiscal year, 60 days ago: −$3.88 Current fiscal year, 30 days ago: −$3.79 Current fiscal year, 7 days ago: −$3.79 Current fiscal year, Now: −$3.79 −$3.79 Next fiscal year, 90 days ago: $0.26 Next fiscal year, 60 days ago: $0.14 Next fiscal year, 30 days ago: $0.16 Next fiscal year, 7 days ago: $0.16 Next fiscal year, Now: $0.16 $0.16

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.92$0.26
60 days ago −$3.88$0.14
30 days ago −$3.79$0.16
7 days ago −$3.79$0.16
Now −$3.79$0.16

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.06 −$0.04 +27.2%
Mar 2026 −$0.05 −$0.11 −119.6%
Dec 2025 −$0.12 −$0.18 −53.4%
Sept 2025 $0.07 −$0.20 −382.9%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, July 28, 2026

No numeric guidance in Core Scientific, Inc.'s latest earnings release (filed July 28, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

22 analysts, Oct 2026
Buy2091%
Hold29%
Sell00%

Monthly trend

  1. Oct 2026317222
  2. Sep 2026317222
  3. Aug 202631317
  4. Jul 202631317

Counts of recommendations published by analysts covering Core Scientific, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
27.0%
of tradable shares
Days to cover
5.77
at average volume
Short interest, 1 month
+21%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
1.4%
of shares
Employees
325
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −41.9%

$21.54 on October 31, 2025 to $12.51

ThenNowEffect
Revenue (last 12 months) $348m $440m +26.4%
P/S multiple 19.2x 8.8x −54.2%
Share count 311m 310m +0.4%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 20252026 to date
Return
CORZ+4%−14%
Industry peers (median)−12%−30%
S&P 500+18%+11%
Months that ended higher
CORZ50%27%
S&P 50075%46%
Largest fall from a high during the year
CORZ−61%−57%
S&P 500−19%−9%

Worst fall since January 24, 2024: 65% from November 22, 2024 to April 21, 2025. Getting back needed a 185% gain, reached on October 10, 2025, 172 days after the low.

Price behaviour

52-week range
$12.51 – $29.16
From 52-week high
−57.1%
vs 50-day average
−22.3%
vs 200-day average
−36.3%
Volatility (1 year)
73%
Beta vs S&P 500
3.08

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
8 up, 3 down
typical move ±9.6%
After a week
6 up, 5 down
typical move ±11.8%
After a month
5 up, 6 down
typical move ±27.0%
Results releasedNext dayS&P 500 next day5 days21 days
July 28, 2026 −12.6% −1.3% +10.0% −16.0%
May 6, 2026 +0.8% +1.1% +8.2% +16.5%
March 2, 2026 −9.8% −0.8% −10.7% −11.8%
October 24, 2025 +10.0% +2.0% +19.3% −12.8%
August 8, 2025 +1.3% +0.6% −1.5% +1.3%
May 7, 2025 +5.1% +1.1% +14.8% +35.6%
February 26, 2025 +9.7% −1.5% −1.7% −19.3%
November 6, 2024 +26.4% +3.3% +23.9% +30.5%
August 7, 2024 +4.4% +1.6% −9.4% −4.0%
May 8, 2024 +15.4% +0.6% +13.3% +130.2%
March 12, 2024 −10.5% +0.9% −17.0% −19.1%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Core Scientific, Inc. in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Core Scientific, Inc.
$300M $400M $500M $600M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $481.7M Revenue (TTM), FY23 Q4: $502.4M Revenue (TTM), FY24 Q1: $561M Revenue (TTM), FY24 Q2: $575.2M Revenue (TTM), FY24 Q3: $557.7M Revenue (TTM), FY24 Q4: $510.7M Revenue (TTM), FY25 Q1: $410.9M Revenue (TTM), FY25 Q2: $348.4M Revenue (TTM), FY25 Q3: $334.2M Revenue (TTM), FY25 Q4: $319M Revenue (TTM), FY26 Q1: $354.7M Revenue (TTM), FY26 Q2: $440.3M $440.3M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $481.7M
FY23 Q4 $502.4M
FY24 Q1 $561M
FY24 Q2 $575.2M
FY24 Q3 $557.7M
FY24 Q4 $510.7M
FY25 Q1 $410.9M
FY25 Q2 $348.4M
FY25 Q3 $334.2M
FY25 Q4 $319M
FY26 Q1 $354.7M
FY26 Q2 $440.3M
Revenue growth, TTM YoY Core Scientific, Inc.
-60% -40% -20% 0% 20% 40% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -41.3% Revenue growth, TTM YoY, FY23 Q4: -21.5% Revenue growth, TTM YoY, FY24 Q1: -1.3% Revenue growth, TTM YoY, FY24 Q2: 8.2% Revenue growth, TTM YoY, FY24 Q3: 15.8% Revenue growth, TTM YoY, FY24 Q4: 1.6% Revenue growth, TTM YoY, FY25 Q1: -26.8% Revenue growth, TTM YoY, FY25 Q2: -39.4% Revenue growth, TTM YoY, FY25 Q3: -40.1% Revenue growth, TTM YoY, FY25 Q4: -37.5% Revenue growth, TTM YoY, FY26 Q1: -13.7% Revenue growth, TTM YoY, FY26 Q2: 26.4% 26.4%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -41.3%
FY23 Q4 -21.5%
FY24 Q1 -1.3%
FY24 Q2 8.2%
FY24 Q3 15.8%
FY24 Q4 1.6%
FY25 Q1 -26.8%
FY25 Q2 -39.4%
FY25 Q3 -40.1%
FY25 Q4 -37.5%
FY26 Q1 -13.7%
FY26 Q2 26.4%
Operating margin (TTM) Core Scientific, Inc.
-150% -100% -50% 0% 50% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -131.0% Operating margin (TTM), FY23 Q4: 1.8% Operating margin (TTM), FY24 Q1: 10.1% Operating margin (TTM), FY24 Q2: -7.6% Operating margin (TTM), FY24 Q3: -13.0% Operating margin (TTM), FY24 Q4: -27.8% Operating margin (TTM), FY25 Q1: -59.5% Operating margin (TTM), FY25 Q2: -51.6% Operating margin (TTM), FY25 Q3: -57.9% Operating margin (TTM), FY25 Q4: -77.0% Operating margin (TTM), FY26 Q1: -143.5% Operating margin (TTM), FY26 Q2: -127.4% -127.4%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -131.0%
FY23 Q4 1.8%
FY24 Q1 10.1%
FY24 Q2 -7.6%
FY24 Q3 -13.0%
FY24 Q4 -27.8%
FY25 Q1 -59.5%
FY25 Q2 -51.6%
FY25 Q3 -57.9%
FY25 Q4 -77.0%
FY26 Q1 -143.5%
FY26 Q2 -127.4%
FCF margin (TTM) Core Scientific, Inc.
-300% -200% -100% 0% 100% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 3.0% FCF margin (TTM), FY23 Q4: 9.7% FCF margin (TTM), FY24 Q1: 3.7% FCF margin (TTM), FY24 Q2: 0.2% FCF margin (TTM), FY24 Q3: -4.9% FCF margin (TTM), FY24 Q4: -10.2% FCF margin (TTM), FY25 Q1: -41.7% FCF margin (TTM), FY25 Q2: -73.7% FCF margin (TTM), FY25 Q3: -102.9% FCF margin (TTM), FY25 Q4: -141.3% FCF margin (TTM), FY26 Q1: -130.0% FCF margin (TTM), FY26 Q2: -217.5% -217.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 3.0%
FY23 Q4 9.7%
FY24 Q1 3.7%
FY24 Q2 0.2%
FY24 Q3 -4.9%
FY24 Q4 -10.2%
FY25 Q1 -41.7%
FY25 Q2 -73.7%
FY25 Q3 -102.9%
FY25 Q4 -141.3%
FY26 Q1 -130.0%
FY26 Q2 -217.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 60 544 640 502 511 319 440
Gross profit 9 239 8 123 121 38 125
EBITDA 3 165 −1,884 105 −29 −177 −499
Operating income −6 131 −2,110 9 −142 −246 −561
Net income −12 47 −2,146 −246 −1,438 −289 −1,431
Diluted EPS −$0.14 $0.20 −$6.30 −$0.65 −$4.87 −$0.88 −$4.62
Growth (year on year)
Revenue — +802.7% +17.6% −21.5% +1.6% −37.5% +26.4%
EBITDA — +>999% <−999% — −127.5% — —
Operating income — — <−999% — — — —
Net income — — <−999% — — — —
Diluted EPS — — <−999% — — — —
Margins
Gross margin 15.6% 43.9% 1.3% 24.6% 23.7% 11.9% 28.3%
EBITDA margin 5.1% 30.3% −294.3% 20.9% −5.7% −55.4% −113.3%
Operating margin −10.5% 24.2% −329.5% 1.8% −27.8% −77.0% −127.4%
Net margin −20.2% 8.7% −335.2% −49.1% −281.6% −90.5% −324.9%
Free-cash-flow margin −39.4% −10.4% −27.9% 9.7% −10.2% −141.3% −217.5%
Cash flow
Cash from operations −24 −57 205 65 43 278 520
Capital spending 0 0 384 16 95 729 1,478
Free cash flow −24 −57 −179 49 −52 −451 −958
Stock-based pay 3 39 183 59 52 98 94
Free cash flow after stock pay −27 −96 −362 −10 −104 −549 −1,052
Balance sheet
Cash 9 118 16 50 836 311 1,770
Total debt 0 728 36 808 1,090 1,085 4,385
Net debt (negative = net cash) −9 610 20 758 254 774 2,615
Diluted shares 158m 233m 341m 380m 256m 318m 310m
Returned to shareholders
Buybacks — — 32 0 0 — —
Total returned — — 32 0 0 — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

Diluted share count
−0.4%
year over year
Sales & admin spending
34.5%
of revenue

Competitors: side by side with peers

Closest by revenue in internet services & infrastructure
Last 12 months unless stated CORZ FVRR FUFU NBIS HUT RIOT Median
Revenue, last 12 months $440m $431m $478m $530m $318m $675m $242m
Revenue growth, last 12 months 26.4% 10.1% 3.1% 479.0% 129.5% 24.5% 8.3%
Revenue growth, 3-year average −6.1% — — −24.0% 57.0% 38.0% 7.6%
Revenue growth, latest quarter 108.8% — — — 81.4% 13.9% 5.5%
Gross margin 28.3% 81.6% 6.1% 68.6% 62.3% 62.4% 49.5%
Operating margin −127.4% −0.3% −5.0% −115.5% −295.3% −199.2% −56.0%
Operating margin, 3-year average −62.2% −17.7% — −35.1% 21.9% −58.8% −25.3%
Net margin −324.9% 4.9% −6.5% 15.6% −188.6% −196.3% −55.8%
Cash from operations / revenue 118.2% 24.3% −23.6% 72.6% −28.1% −73.0% −10.4%
Free-cash-flow margin −217.5% 24.1% −29.5% −694.8% −74.0% −115.1% −25.9%
Free-cash-flow margin, 3-year average −97.0% 7.3% — −230.9% −86.7% −114.1% −17.4%
Stock pay / revenue 21.3% 11.9% 0.1% 15.7% 46.8% 20.9% 11.9%
Change in share count −0.4% −1.8% 2.5% −11.9% −3.0% 44.8% 5.2%

Median of all 34 companies we cover in internet services & infrastructure. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

34 internet services & infrastructure companies
Measure Company Peer median Rank
Revenue growth Growth 26.4% 10.1% 7 of 34
Change in growth rate Growth +40.0pp -0.6pp 2 of 34
Operating margin Profitability -127.4% -49.3% 22 of 33
Net margin Profitability -324.9% -47.1% 27 of 34
Stock pay as % of revenue Cash generation 21.3% 12.4% 26 of 32
Long-term debt as % of assets Balance sheet 81.7% 20.2% 23 of 25
Change in share count Balance sheet -0.4% 5.2% 8 of 26

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$9.3B
Institutions reporting
410
Shares held vs prior quarter
▼ 5.7%
Positions opened / closed
84 / 64

Top buyers and sellers, Q2 2026: 223 institutions bought and 190 sold ; the biggest buyer was Jericho Capital Asset Management L.P (+11.2M shares) and the biggest seller Pentwater Capital Management LP (−24.3M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $720M 28.1M 7.7% ▲ 14.2%
Situational Awareness LP $666M 26.0M 7.1% 0.0%
Jericho Capital Asset Management L.P. $586M 22.9M 6.3% ▲ 95.2%
Vanguard Portfolio Management LLC $478M 18.7M 5.1% ▲ 0.3%
UBS Group AG $407M 15.9M 4.3% ▼ 37.8%
Vanguard Capital Management LLC $353M 13.8M 3.8% ▲ 3.2%
Two Sigma Investments, LP $263M 10.3M 2.8% ▲ 84.0%
Geode Capital Management, LLC $245M 8.5M 2.6% ▲ 8.9%
Value Aligned Research Advisors, LLC $235M 9.2M 2.5% ▲ 19.0%
Two Seas Capital LP $231M 9.0M 2.5% ▼ 44.1%
State Street Corp $198M 7.7M 2.1% ▲ 6.3%
Valiant Capital Management, L.P. $191M 7.5M 2.0% ▲ 9.1%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Core Scientific, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $551,500 5 trades by 2 insiders, last 12 months Insider sales History → $6.4M 49 trades by 1 insider · 100% under pre-set plans
Net ▼ $5.8M net selling
Insider Date Trade Shares Price Value
Duchene Todd M See remarks October 26, 2026 Sell pre-set plan 5,500 $13.80 $75,900
Duchene Todd M See remarks October 26, 2026 Sell pre-set plan 4,500 $13.27 $59,694
Duchene Todd M See remarks October 19, 2026 Sell pre-set plan 10,000 $13.87 $138,744
Duchene Todd M See remarks October 12, 2026 Sell pre-set plan 10,000 $15.12 $151,160
Duchene Todd M See remarks October 5, 2026 Sell pre-set plan 10,000 $16.31 $163,056
Duchene Todd M See remarks September 28, 2026 Sell pre-set plan 10,000 $16.76 $167,600
Duchene Todd M See remarks September 21, 2026 Sell pre-set plan 10,000 $18.37 $183,700
Weiss Eric Stanton Director September 15, 2026 Buy 6,000 $16.33 $97,980
Duchene Todd M See remarks September 14, 2026 Sell pre-set plan 10,000 $17.14 $171,400
Duchene Todd M See remarks September 8, 2026 Sell pre-set plan 10,000 $18.67 $186,700
Duchene Todd M See remarks August 31, 2026 Sell pre-set plan 10,000 $16.23 $162,300
Duchene Todd M See remarks August 24, 2026 Sell pre-set plan 10,000 $17.45 $174,500

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around October 23, 2026 estimated from the company's past filing pattern, not announced

  • July 28, 2026
  • May 6, 2026
  • March 2, 2026
  • October 24, 2025
  • August 8, 2025
  • May 7, 2025

Recent SEC filings

Data status

When each part of this page on Core Scientific, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Core Scientific, Inc. in brief

What does Core Scientific, Inc. do?
Core Scientific, Inc. is a US-listed company in the internet services & infrastructure industry. Its financial year ends in December.
What is Core Scientific, Inc.'s stock ticker?
Core Scientific, Inc. trades under the ticker CORZ on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Core Scientific, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Core Scientific, Inc. reported revenue of $440M, 26.4% higher than a year earlier, according to its SEC filings.
What is Core Scientific, Inc.'s free cash flow?
Core Scientific, Inc.'s free-cash-flow margin is -217.5% of revenue over the trailing twelve months.
Who are Core Scientific, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Situational Awareness LP and Jericho Capital Asset Management L.P. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Core Scientific, Inc.'s market cap?
On November 2, 2026, Core Scientific, Inc.'s market capitalisation was about $3.9B and net debt of $2.6B. Market figures come from third-party market data and may be delayed.
Who are Core Scientific, Inc.'s competitors?
In our Internet Services & Infrastructure peer group, the companies closest to Core Scientific, Inc. are Fiverr International Ltd., Bitfufu Inc., Nebius Group N.V., Hut 8 Corp. and Riot Platforms, Inc. The side-by-side comparison below sets their revenue, margins and growth against Core Scientific, Inc.'s.
Are insiders buying or selling Core Scientific, Inc. stock?
Over the last 12 months, Core Scientific, Inc.'s directors and officers reported 5 open-market purchases and 49 sales on Form 4. The insider trading page charts every trade.
When is Core Scientific, Inc.'s next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Core Scientific, Inc. announces its own schedule.